Pre-clinical & IND-enabling

Critical data to confidently advance therapeutics into clinical trials

Advancing Pharmaceuticals to Clinical Readiness

MRIGlobal’s pre-clinical and IND-enabling services generate the critical safety, toxicology, pharmacology, and efficacy data needed to support an Investigational New Drug (IND) application and advance pharmaceutical candidates into clinical trials. Our team delivers the scientific expertise, regulatory insight, and high-quality data needed to move promising therapeutics forward with confidence.

Supporting the Path to Clinical Trials

Produce regulatory-compliant data that can accelerate development and reduce risk.

Optimize formulations that help reduce development risk and accelerate clinical readiness.

Integrate GLP-compliant documentation and scientific expertise into regulatory-ready submissions.

MRIGlobal Expert

Get in Touch

Welcome to the new MRIGlobal site. Built to carry our mission forward. Discover what's new!

X